Skip to content

Clinical trials

Post-Acute COVID-19 Syndrome trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Country / region: United Kingdom Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20202
20215
20224
20237
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status7
Not yet recruiting4
Active, not recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University College, London4
King's College London2
Oxford Brookes University2
Sheffield Hallam University2
Axcella Health, Inc1
Bod Australia1
Bournemouth University1
HCA International Limited1
London School of Hygiene and Tropical Medicine1
NHS Greater Glasgow and Clyde1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome27
COVID-198
Asthma3
Dyspnea3
Fatigue3
Fatigue Syndrome, Chronic3
Heart Failure3
Pulmonary Disease, Chronic Obstructive3
Stroke3
Anxiety Disorders2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.